Grape Pomace Polyphenols and Cardiometabolic Risk (GRAPOM)
Primary Purpose
Subjects at Cardiometabolic Risk
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
GRAPOM
Sponsored by
About this trial
This is an interventional basic science trial for Subjects at Cardiometabolic Risk focused on measuring Polyphenols, Metabolic syndrome, Cardiometabolic risk, Grape pomace, Postprandial glucose, Insulin resistance, Obesity
Eligibility Criteria
Inclusion Criteria:
At least two of the following requirements:
- BMI ≥ 25 kg/m2.
- Fasting glucose values ≥ 100 mg/dL.
- Triglycerides ≥ 150 mg/dL.
- HDL-cholesterol: ≤ 50 mg/dL women, ≤ 40 mg/dL men.
- Blood pressure: systolic ≥ 130 mm Hg or diastolic ≥ 85 mm Hg.
Exclusion Criteria:
- Subjects with a pharmaceutical treatment set to modify blood pressure, lipid profile or glucose.
- Volunteers participating in other studies or weight loss plans.
- Pregnant or breastfeeding women.
Sites / Locations
- Institute of Food Science, Technology and Nutrition (ICTAN-CSIC)
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
GRAPOM
CTR
Arm Description
Daily consumption for 6 weeks of 10 g of dried and milled grape pomaces solved in water. Samples will be collected at the beginning and the end of this period
Follow-up for 6 weeks without intervention. Samples will be collected at the beginning and the end of this period
Outcomes
Primary Outcome Measures
Fasting insulin
Changes of blood insulin fasting levels as result of long-term supplementation with grape pomace (GRAPOM).
Fasting glucose
Changes of blood glucose fasting levels as result of long-term supplementation with grape pomace (GRAPOM).
Secondary Outcome Measures
Postprandial glucose
Changes of blood glucose response after an oral glucose load as result of long-term supplementation with grape pomace (GRAPOM).
Postprandial insulin
Changes of blood insulin response after an oral glucose load as result of long-term supplementation with grape pomace (GRAPOM).
Blood pressure
Changes of blood pressure as result of long-term supplementation with grape pomace (GRAPOM).
Blood cholesterol (total, HDL, LDL)
Changes of blood cholesterol (total, HDL, LDL) as result of long-term supplementation with grape pomace (GRAPOM).
Blood triglycerides
Changes of blood triglycerides as result of long-term supplementation with grape pomace (GRAPOM).
Blood C reactive protein
Changes of blood C reactive protein as result of long-term supplementation with grape pomace (GRAPOM).
Blood fibrinogen
Changes of blood fibrinogen as result of long-term supplementation with grape pomace (GRAPOM).
Blood uric acid
Changes of blood uric acid as result of long-term supplementation with grape pomace (GRAPOM).
Iron metabolism
Changes of blood markers of iron metabolism as result of long-term supplementation with grape pomace (GRAPOM).
Blood polyphenols
Changes of blood polyphenols as result of long-term supplementation with grape pomace (GRAPOM).
Urine uric acid
Changes of urine uric acid as result of long-term supplementation with grape pomace (GRAPOM).
Urine polyphenols
Changes of urine polyphenols as result of long-term supplementation with grape pomace (GRAPOM).
Body weight
Changes of body weight (measured at a body-impedance equipment) as result of long-term supplementation with grape pomace (GRAPOM).
Body fat
Changes of body fat as result of long-term supplementation with grape pomace (GRAPOM).
miRNA expression
Changes of blood expression of selected miRNA as result of long-term supplementation with grape pomace (GRAPOM).
Profile of fecal microbiota
Changes of fecal microbiota as result of long-term supplementation with grape pomace (GRAPOM).
Full Information
NCT ID
NCT03076463
First Posted
February 26, 2017
Last Updated
April 4, 2018
Sponsor
National Research Council, Spain
Collaborators
University of the Basque Country (UPV/EHU)
1. Study Identification
Unique Protocol Identification Number
NCT03076463
Brief Title
Grape Pomace Polyphenols and Cardiometabolic Risk
Acronym
GRAPOM
Official Title
Long-term Effects of Grape Polyphenols as Modulators of Metabolic Syndrome in Humans
Study Type
Interventional
2. Study Status
Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
March 10, 2017 (Actual)
Primary Completion Date
July 7, 2017 (Actual)
Study Completion Date
December 20, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Research Council, Spain
Collaborators
University of the Basque Country (UPV/EHU)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this is study is to evaluate the long-term effects of grape polyphenols in the modulation of markers of metabolic syndrome. Most of the previous works about polyphenols have only considered a fraction of polyphenols, i.e., extractable polyphenols. As a consequence, an important amount of dietary polyphenols, the so-called non-extractable polyphenols are ignored. In contrast, the effect of both extractable and non-extractable polyphenols will be considered in this study. Also, studies on the long-term effect of grape polyphenol on markers of metabolic syndrome have been mostly conducted in animals, so clinical trials on this topic are needed.
Detailed Description
Fifty supposedly healthy volunteers with at least two cardiometabolic risk factors were recruited. The cardiometabolic risk factors used to select the subjects are described below.
The whole intervention will be divided in 2 periods, control (CTR) and dried and milled grape pomace (GRAPOM). The two periods will have a duration of 6 weeks. During the CTR period, subjects will follow their normal dietary habits and samples will be collected at the beginning and at the end. No proper placebo could be found for the product, so this CTR period was chosen. During the GRAPOM period, the subjects will daily consume 8 g of the product solved in water and samples will be collected at the beginning and at the end.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Subjects at Cardiometabolic Risk
Keywords
Polyphenols, Metabolic syndrome, Cardiometabolic risk, Grape pomace, Postprandial glucose, Insulin resistance, Obesity
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
GRAPOM: dried and milled grape pomaces. CTR: control period. All the subjects will pass the two periods: one half will do the CTRL period followed by the GRAPOM period, and the other half will do it inversely. The assignment to each order will be done randomly. Both period will be separated by a four weeks washing period.
Masking
Investigator
Allocation
Randomized
Enrollment
49 (Actual)
8. Arms, Groups, and Interventions
Arm Title
GRAPOM
Arm Type
Experimental
Arm Description
Daily consumption for 6 weeks of 10 g of dried and milled grape pomaces solved in water. Samples will be collected at the beginning and the end of this period
Arm Title
CTR
Arm Type
No Intervention
Arm Description
Follow-up for 6 weeks without intervention. Samples will be collected at the beginning and the end of this period
Intervention Type
Dietary Supplement
Intervention Name(s)
GRAPOM
Intervention Description
The whole intervention will be divided in 2 periods, control (CTR) and dried and milled grape pomace (GRAPOM). The two periods will have a duration of 6 weeks. During the CTR period, subjects will follow their normal dietary habits and samples will be collected at the beginning and at the end. No proper placebo could be found for the product, so this CTR period was chosen. During the GRAPOM period, the subjects will daily consume 8 g of the product solved in water and samples will be collected at the beginning and at the end.
Primary Outcome Measure Information:
Title
Fasting insulin
Description
Changes of blood insulin fasting levels as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to three months
Title
Fasting glucose
Description
Changes of blood glucose fasting levels as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to three months
Secondary Outcome Measure Information:
Title
Postprandial glucose
Description
Changes of blood glucose response after an oral glucose load as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to four months
Title
Postprandial insulin
Description
Changes of blood insulin response after an oral glucose load as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to four months
Title
Blood pressure
Description
Changes of blood pressure as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to four months
Title
Blood cholesterol (total, HDL, LDL)
Description
Changes of blood cholesterol (total, HDL, LDL) as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to four months
Title
Blood triglycerides
Description
Changes of blood triglycerides as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to four months
Title
Blood C reactive protein
Description
Changes of blood C reactive protein as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to five months
Title
Blood fibrinogen
Description
Changes of blood fibrinogen as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to five months
Title
Blood uric acid
Description
Changes of blood uric acid as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to five months
Title
Iron metabolism
Description
Changes of blood markers of iron metabolism as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to six months
Title
Blood polyphenols
Description
Changes of blood polyphenols as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to six months
Title
Urine uric acid
Description
Changes of urine uric acid as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to six months
Title
Urine polyphenols
Description
Changes of urine polyphenols as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to seen months
Title
Body weight
Description
Changes of body weight (measured at a body-impedance equipment) as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to three months
Title
Body fat
Description
Changes of body fat as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to seven months
Title
miRNA expression
Description
Changes of blood expression of selected miRNA as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to eight months
Title
Profile of fecal microbiota
Description
Changes of fecal microbiota as result of long-term supplementation with grape pomace (GRAPOM).
Time Frame
Up to nine months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
At least two of the following requirements:
BMI ≥ 25 kg/m2.
Fasting glucose values ≥ 100 mg/dL.
Triglycerides ≥ 150 mg/dL.
HDL-cholesterol: ≤ 50 mg/dL women, ≤ 40 mg/dL men.
Blood pressure: systolic ≥ 130 mm Hg or diastolic ≥ 85 mm Hg.
Exclusion Criteria:
Subjects with a pharmaceutical treatment set to modify blood pressure, lipid profile or glucose.
Volunteers participating in other studies or weight loss plans.
Pregnant or breastfeeding women.
Facility Information:
Facility Name
Institute of Food Science, Technology and Nutrition (ICTAN-CSIC)
City
Madrid
ZIP/Postal Code
28040
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Grape Pomace Polyphenols and Cardiometabolic Risk
We'll reach out to this number within 24 hrs